Publication | Open Access
Conjugating Prussian Blue Nanoparticles Onto antigen-specific T Cells As a Combined Nanoimmunotherapy
61
Citations
15
References
2016
Year
This study highlights the potential of our CTL:PBNPs nanoimmunotherapy as a novel therapeutic for treating virus-associated malignancies such as EBV+ cancers.
| Year | Citations | |
|---|---|---|
Page 1
Page 1